Free Trial

7 Consumer Discretionary Stocks That Will Continue to Rally - 6 of 7

 
 

#6 - Birkenstock (NYSE:BIRK)

Birkenstock Holding plc (NYSE: BIRK) was a much-anticipated initial public offering (IPO) in October 2023. Just over one year since its public debut, BIRK stock is up about 14% despite a 20% drop in the three months ending November 11, 2024.  

The reason is earnings, which came in a little lighter in the company’s most recent quarter. That’s spooking investors who are concerned that the company known for its iconic luxury sandals may be facing a weary consumer.  

But Birkenstock’s business model is one that delights in leaving retailers wanting more. The Wall Street Journal wrote that the brand “typically ships retailers about 75% of what they would like to order.” That’s creating a scarcity that increases the urgency to buy.  

Analysts clearly see the stock’s dip as a buying opportunity. The stock maintains a Moderate Buy rating with a $66.40 price target, representing a 42% increase in the stock price.  

About Birkenstock

Birkenstock Holding plc manufactures and sells footwear products. It also offers sandals, shoes, closed-toe silhouettes, skincare products, and accessories. The company sells its products through e-commerce sites and a network of owned retail stores, as well as business-to-business channels. It operates in the United States, Brazil, Canada, Mexico, Europe, APMA, and internationally. Read More 
Current Price
$46.27
Consensus Rating
Moderate Buy
Ratings Breakdown
13 Buy Ratings, 2 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$66.40 (43.5% Upside)

 

Dylan Jovine's #1 Retirement Play for 2024 (Ad)

Register: My First LIVE Event in 5 Years! On Tuesday, November 19th, I'm breaking my "no webinars" rule and going LIVE at 8:00pm Eastern. You won't want to miss this event. I'm releasing my No. 1 Retirement Play in 2024. It has nothing to do with regular stocks, options, cryptos or any investment fads.

Click here now to register for "Our #1 Takeover Target for November" event.